Shares of Johnson Matthey (OTCMKTS:JMPLY) have been given a consensus rating of “Hold” by the six research firms that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and three have assigned a buy recommendation to the company.

Several research firms recently weighed in on JMPLY. Zacks Investment Research downgraded shares of Johnson Matthey from a “buy” rating to a “hold” rating in a report on Saturday, April 20th. Investec downgraded shares of Johnson Matthey from a “hold” rating to a “sell” rating in a report on Friday, April 12th.

Shares of OTCMKTS JMPLY traded up $1.77 during midday trading on Tuesday, reaching $80.00. 746 shares of the stock were exchanged, compared to its average volume of 1,298. The company has a market capitalization of $7.74 billion, a P/E ratio of 14.49, a P/E/G ratio of 1.28 and a beta of 1.50. Johnson Matthey has a twelve month low of $67.00 and a twelve month high of $102.55.

Johnson Matthey Company Profile

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Recommended Story: Why do companies pay special dividends?

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.